Compare CPOP & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPOP | IINN |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 35.3M |
| IPO Year | 2021 | 2021 |
| Metric | CPOP | IINN |
|---|---|---|
| Price | $0.46 | $0.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 41.6K | ★ 183.9K |
| Earning Date | 11-17-2025 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $107,632,769.00 | $289,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9,715.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 127.16 | N/A |
| 52 Week Low | $0.39 | $0.40 |
| 52 Week High | $2.61 | $1.65 |
| Indicator | CPOP | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | 27.63 |
| Support Level | $0.44 | $0.92 |
| Resistance Level | $0.50 | $0.97 |
| Average True Range (ATR) | 0.03 | 0.08 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 24.93 | 4.82 |
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.